Literature DB >> 9477210

Obstetric care for renal allograft recipients or for women treated with hemodialysis or peritoneal dialysis during pregnancy.

M J Hussey1, X Pombar.   

Abstract

Pregnancies in women on dialysis and in women who have had renal transplant are no longer uncommon. Optimal obstetric outcomes require a multidisciplinary team approach, patient counseling, and clinicians who are knowledgeable and experienced in taking care of these patients. Counseling should begin before pregnancy, and all reproductive age women on dialysis and who have undergone renal transplant should receive family planning counseling. Preconceptional counseling should be provided to those patients who desire pregnancy. If the patient presents in early pregnancy, she should be informed about the maternal and fetal risks associated with her pregnancy. Prenatal care must include intensive surveillance for hypertension, preeclampsia, preterm labor, intrauterine growth restriction, anemia, infection, and renal allograft rejection. Aggressive treatment of complications is mandatory. There are limitations to our current knowledge about pregnancies in these patients. It is important for clinicians who provide care for these patients to be aware of these limitations when making obstetric management decisions. Cesarean section should be reserved for usual obstetric indications. Breast-feeding is not advised in patients taking cyclosporin or azathioprine. Transplant patients have unique gynecologic needs, so they should be encouraged to pursue follow-up gynecologic care after the pregnancy.

Entities:  

Mesh:

Year:  1998        PMID: 9477210     DOI: 10.1016/s1073-4449(98)70009-3

Source DB:  PubMed          Journal:  Adv Ren Replace Ther        ISSN: 1073-4449


  2 in total

1.  Pregnancy in peritoneal dialysis: a case report and review of adequacy and outcomes.

Authors:  William T Smith; Shabnam Darbari; Mindy Kwan; Christopher O Reilly-Green; Maria V Devita
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 2.  Pregnancy and renal failure: the case for application of dosage guidelines.

Authors:  F Keller; M Griesshammer; U Häussler; W Paulus; A Schwarz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.